News in the Life Sciences Industry

ERFURT and BERLIN, Germany, July 21, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP" or the "Company") (FSE: C4T) (ISIN: CA00176G1028) (CSE: XCX) announces it has placed two orders for bulk and finished EU-GMP medical cannabis flower from a Canadian Licensed Producer ("Canadian LP") of medical... Read more ››

ERFURT and BERLIN, Germany, July 21, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP" or the "Company") (FSE: C4T) (ISIN: CA00176G1028) (CSE: XCX) announces it has placed two orders for bulk and finished EU-GMP medical cannabis flower from a Canadian Licensed Producer ("Canadian LP") of medical... Read more ››

ROTTERDAM, Netherlands, July 20, 2020 /PRNewswire/ -- Viroclinics Biosciences B.V. ("Viroclinics") today announced the appointment of life sciences industry veteran Davide Molho, DVM as the company's new Chief Executive Officer. Dr. Molho succeeds Bob van Gemen, PhD who has served as the company's... Read more ››

SINGAPORE, July 20, 2020 /PRNewswire/ -- Docquity, Southeast Asia's largest professional network of doctors, has partnered with Swiss research-based healthcare company Novartis to deliver bite-sized, continual learning, and education support to doctors across seven countries in Asia. Novartis... Read more ››

IPSWICH, Mass., July 17, 2020 /PRNewswire/ -- The novel coronavirus, SARS-CoV-2, has continued to spread, increasing the number of COVID-19 cases and adversely impacting communities and businesses. Despite the challenges the virus has presented, scientists and research institutions across the... Read more ››

ABBOTT PARK, Ill., July 16, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2020.

From 15 to 19 July, Esaote will take part in the Virtual Expo with a booth space where visitors can discover the latest ultrasound, dedicated MRI and healthcare IT technologies.

CAMBRIDGE, Mass. and SHANGHAI, July 13, 2020 /CNW/ -- Revitope Oncology Inc ("Revitope Oncology")., a biotechnology company advancing a new class of precision cancer immunotherapies, its wholly-owned subsidiary Revitope Limited (Revitope Limited, together with Revitope Oncology, "Revitope") and... Read more ››

- Prof. Sieber is developing approaches against multi-resistant pathogens at the Technical University of Munich